Sivik Global Healthcare LLC / BSX
Sivik Global Healthcare LLC’s Boston Scientific Corp Position
Does Sivik Global Healthcare LLC own Boston Scientific Corp (BSX)? Yes — 62.0K shares worth $4M (+2.95% of its 13F portfolio) as of Q1 2026, down from 70.0K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
62.0K
% of Portfolio
+2.95%
Quarters Held
29
currently held
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 62.0K | $4M | +2.95% |
| Q4 2025 | 70.0K | $7M | +1.94% |
| Q3 2025 | 70.0K | $7M | +1.99% |
| Q2 2025 | 80.0K | $9M | +2.34% |
| Q1 2025 | 100.0K | $10M | +5.45% |
| Q4 2024 | 110.0K | $10M | +5.17% |
| Q3 2024 | 105.0K | $9M | +3.73% |
| Q2 2024 | 115.0K | $9M | +3.18% |
| Q1 2024 | 135.0K | $9M | +2.17% |
| Q4 2023 | 160.0K | $9M | +3.86% |
| Q3 2023 | 160.0K | $8M | +4.27% |
| Q2 2023 | 160.0K | $9M | +2.02% |
| Q1 2023 | 155.0K | $8M | +3.33% |
| Q4 2022 | 185.0K | $9M | +4.03% |
| Q3 2022 | 185.0K | $7M | +3.98% |
| Q2 2022 | 185.0K | $7M | +3.92% |
| Q1 2022 | 200.0K | $9M | +3.66% |
| Q4 2021 | 160.0K | $7M | +2.91% |
| Q3 2021 | 220.0K | $10M | +2.28% |
| Q2 2021 | 190.0K | $8M | +1.59% |
| Q1 2021 | 225.0K | $9M | +3.17% |
| Q4 2020 | 200.0K | $7M | +2.93% |
| Q3 2020 | 170.0K | $6M | +2.79% |
| Q1 2020 | 7.5K | $4M | +1.47% |
| Q4 2019 | 175.0K | $8M | +2.94% |
| Q3 2019 | 200.0K | $8M | +4.11% |
| Q2 2019 | 200.0K | $9M | +2.08% |
| Q1 2019 | 225.0K | $9M | +3.18% |
| Q4 2018 | 220.0K | $8M | +4.19% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of BSX.